Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
Norihide FukushimaEisuke TatsumiOsamu SeguchiYoshiaki TakewaToshimitsu HamasakiKaori OndaHaruko YamamotoTeruyuki HayashiTomoyuki FujitaJunjiro KobayashiPublished in: Cardiovascular drugs and therapy (2019)
UMIN Clinical Trials Registry (UMIN-CTR; R000033243) registered on 8 September 2017.